Healthy volunteers needed to test two versions of a gastritis drug
NCT ID NCT07385248
First seen Feb 04, 2026 · Last updated May 15, 2026 · Updated 15 times
Summary
This early-stage study will compare two versions of a drug (AD-229 and AD-2291) in 28 healthy adults. The goal is to see how the body absorbs each version and to check for any safety concerns. Participants will take both forms at different times, and results will help guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.